We are live on ! Find out more
Ameriprise

Ameriprise Portfolio holdings

AUM $432B
1-Year Est. Return 30.22%
 

Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.

This Fund
S&P 500
This Quarter Est. Return
+10.2%
1 Year Est. Return
+30.22%
3 Year Est. Return
+89.37%
5 Year Est. Return
+112.58%
10 Year Est. Return
+443.56%
AUM
$292B
AUM Growth
+$21.3B
Cap. Flow
-$1.92B
Cap. Flow %
-0.66%
Top 10 Hldgs %
13.2%
Holding
4,135
New
152
Increased
1,522
Reduced
2,111
Closed
185

Top Buys

Rank Stock Value
1
PLD icon
Prologis
PLD
+$504M
2
CI icon
Cigna
CI
+$469M
3
ISRG icon
Intuitive Surgical
ISRG
+$392M
4
PG icon
Procter & Gamble
PG
+$387M
5
PH icon
Parker-Hannifin
PH
+$272M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$357M
2
ADEA icon
Adeia
ADEA
+$356M
3
TGT icon
Target
TGT
+$346M
4
CRM icon
Salesforce
CRM
+$344M
5
LLY icon
Eli Lilly
LLY
+$331M

Sector Composition

Rank Sector Weight
1 Technology 19.58%
2 Healthcare 12.51%
3 Financials 11.68%
4 Industrials 8.82%
5 Consumer Discretionary 6.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RNAC icon
3501
Cartesian Therapeutics
RNAC
$227M
$316K ﹤0.01%
9,288
-182
-2% -$7.74K
SPVM icon
3502
Invesco S&P 500 Value with Momentum ETF
SPVM
$129M
$316K ﹤0.01%
6,406
-1,160
-15% -$57.2K
FMB icon
3503
First Trust Managed Municipal ETF
FMB
$2.04B
$315K ﹤0.01%
6,280
-2,662
-30% -$132K
JETS icon
3504
US Global Jets ETF
JETS
$786M
$315K ﹤0.01%
+18,438
New +$321K
MAV
3505
DELISTED
Pioneer Municipal High Income Advantage Fund
MAV
$315K ﹤0.01%
38,777
-20,426
-35% -$160K
TRIN icon
3506
Trinity Capital Inc.
TRIN
$1.56B
$315K ﹤0.01%
28,835
+3,450
+14% +$40.1K
IBDD
3507
DELISTED
iShares iBonds Mar 2023 Term Corporate ETF
IBDD
$314K ﹤0.01%
+11,837
New +$313K
AVXL icon
3508
Anavex Life Sciences
AVXL
$250M
$312K ﹤0.01%
33,650
+13,895
+70% +$148K
ETB
3509
Eaton Vance Tax-Managed Buy-Write Income Fund
ETB
$449M
$311K ﹤0.01%
23,631
+363
+2% +$5.17K
PSF icon
3510
Cohen & Steers Select Preferred & Income Fund
PSF
$234M
$309K ﹤0.01%
+16,494
New +$313K
DK icon
3511
Delek US
DK
$4.15B
$308K ﹤0.01%
11,419
+1,698
+17% +$50.1K
LZ icon
3512
LegalZoom.com
LZ
$1.35B
$307K ﹤0.01%
39,582
-1,461,956
-97% -$12.7M
FMS icon
3513
Fresenius Medical Care
FMS
$13.8B
$304K ﹤0.01%
18,569
+8,219
+79% +$122K
QDEF icon
3514
FlexShares Quality Dividend Defensive Index Fund
QDEF
$547M
$304K ﹤0.01%
+5,903
New +$299K
EVF
3515
Eaton Vance Senior Income Trust
EVF
$90.1M
$303K ﹤0.01%
57,355
-82,399
-59% -$440K
ADCT icon
3516
ADC Therapeutics
ADCT
$141M
$302K ﹤0.01%
78,670
+1,567
+2% +$6.27K
SPRY icon
3517
ARS Pharmaceuticals
SPRY
$559M
$302K ﹤0.01%
35,410
-1,885
-5% -$12.2K
RXDX
3518
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$302K ﹤0.01%
+2,745
New +$178K
WB icon
3519
Weibo
WB
$1.99B
$299K ﹤0.01%
15,646
+2,748
+21% +$41.4K
IGA
3520
Voya Global Advantage and Premium Opportunity Fund
IGA
$156M
$298K ﹤0.01%
34,353
-6,379
-16% -$55.5K
NVAX icon
3521
Novavax
NVAX
$1.22B
$297K ﹤0.01%
+28,924
New +$510K
HUYA
3522
Huya Inc
HUYA
$570M
$295K ﹤0.01%
+74,764
New +$189K
JEPI icon
3523
JPMorgan Equity Premium Income ETF
JEPI
$45.7B
$295K ﹤0.01%
+5,409
New +$294K
GAB icon
3524
Gabelli Equity Trust
GAB
$1.76B
$293K ﹤0.01%
53,403
-26,994
-34% -$150K
IBMP icon
3525
iShares iBonds Dec 2027 Term Muni Bond ETF
IBMP
$651M
$292K ﹤0.01%
11,644
+1,976
+20% +$48.9K

Similar funds

Ameriprise's Q4 2022 Portfolio in Review

As of Q4 2022, Ameriprise held 4,135 positions worth $292B, up 7.9% from $270B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Ameriprise's Q4 2022 filing shows 152 new, 1,522 increased, 2,111 reduced and 185 closed positions. Its largest new stake was Abcam PLC: 5,014,378 shares worth $78M. The largest sale was CVS Health, an estimated $357M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.

  • Ameriprise's largest Q4 2022 buy was Abcam PLC: 5,014,378 shares worth $78M.
  • Ameriprise added most to Prologis in Q4 2022, an estimated $504M increase.
  • Ameriprise's biggest Q4 2022 reduction was CVS Health, cutting an estimated $357M.
  • Ameriprise fully exited Duke Realty Corp. in Q4 2022, selling an estimated $166M.
  • Ameriprise's ten largest holdings make up 13% of its $292B portfolio in Q4 2022.
  • Ameriprise opened 152 new positions and closed 185 in Q4 2022.
  • Ameriprise's portfolio value rose 7.9% quarter-over-quarter to $292B.

Based on Ameriprise's 13F filing for Q4 2022, filed 14 Feb 2023.